Articles
Competitive Technologies to Display Pain Management Device At BIO International Convention
July 10th, 2008 by Raj Taneja
Competitive Technologies, Inc. (AMEX:CTT) announced today that they will display their pain management therapy device at the BIO International Convention in San Diego, CA from June 17 - 20 (www.bio2008.org). The convention is the world's largest gathering of biotechnology, pharmaceutical, nanotechnology, and medical device leaders.
CTT has exclusive worldwide distribution rights to its pain therapy device, a non-invasive method for rapid treatment of high-intensity oncologic and neuropathic pain, including pain resistant to morphine and other drugs. The CTT device has Medical Device CE certification from the European Union allowing European sales and CTT has applied for FDA 510(k) medical device authorization...
Multitargeted Immune Therapy Scores Well for Severe Lupus Nephritis
July 10th, 2008 by Raj Taneja
NANJING, China, July 2 -- In patients with severe combined lupus nephritis, multitargeted immune therapy led to more than a six-fold increase in the rate of complete remissions compared with intravenous cyclophosphamide, investigators here reported.
Action Points
Explain to patients who ask that a combination of drugs led to more responses than standard therapy in patients with combined severe membranous and proliferative disease.
Note that the study involved a small number of patients.
Note also that the study was conducted in China, and...